Pharmacokinetic and metabolism studies of rohitukine in rats by high performance liquid-chromatography with tandem mass spectrometry |
| |
| Institution: | 1. Pharmacokinetics & Metabolism Div., CSIR — Central Drug Research Institute, Lucknow 226031, India;2. Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, Rafi Marg, New Delhi 110 001, India;3. Medicinal & Process Chemistry Div., CSIR — Central Drug Research Institute, Lucknow 226031, India;4. Pharmacology Div., CSIR — Central Drug Research Institute, Lucknow 226031, India;5. Sophisticated Analytical Facility, CSIR — Central Drug Research Institute, Lucknow 226031, India;1. Department of Urology, Baoji Central Hospital, Baoji, Shaanxi Province, China;2. Xi''an Health Management Service Center, Xi''an, Shaanxi Province, China;3. Department of Medical Psychology, Fourth Military Medical University, Xi''an, Shaanxi Province, China;1. Cardiologia, Ospedale San Paolo, Dipartimento di Scienze della Salute, University of Milan, Italy;2. Divisione di Medicina VI, Ospedale San Paolo, Dipartimento di Scienze della Salute, University of Milan, Italy;3. U.O.C. di Malattie Cardiovascolari, Fondazione IRCCS, Ospedale Maggiore Policlinico, Dipartimento di Scienze Cliniche e di Comunità, University of Milan, Italy |
| |
| Abstract: | A sensitive, selective, and rapid high performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) was developed for the quantification of rohitukine in rat plasma. HPLC was performed using a Symmetry-Shield C18 (5 μ, 4.6 × 150 mm) column, and isocratic elution with ammonium acetate buffer (pH 4; 10 mM):methanol (08:92, v/v) at a flow rate of 0.6 mL/min. Sample clean-up involved solid phase extraction (SPE) of analyte and internal standard (phenacetin) from 100 μL plasma. The parent → product ion transitions (MRM) for analyte and IS were 306.1 → 245.1 m/z and 180.1 → 138.1 m/z respectively, and were monitored on a triple quadrupole mass spectrometer, operating in positive ion mode. The method was validated across the dynamic concentration range of 5–500 ng/mL for rohitukine, with a fast run time of 4.5 min. The analytical method measured concentrations of rohitukine with accuracy (% bias) of <± 10% and precision (% RSD) of <± 12%. Rohitukine was stable during the battery of stability studies viz., bench-top, auto-sampler, freeze/thaw cycles and 30 days of storage in a freezer at ? 70 ± 10 °C. Finally, the applicability of this assay has been successfully demonstrated in vivo pharmacokinetic and in vitro metabolism studies in Sprague–Dawley rat. This method will therefore be highly useful for future preclinical and clinical pharmacokinetic studies of rohitukine. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
